Pretransplant serum CXCL9 and CXCL10 levels fail to predict acute rejection in kidney transplant recipients receiving induction therapy.

Pretransplant serum CXCL9 and CXCL10 levels fail to predict acute rejection in kidney transplant recipients receiving induction therapy.

Dettagli Bibliografici
Autori principali:	Heidt, S, Shankar, S, Muthusamy, A, San Segundo, D, Wood, K
Natura:	Journal article
Lingua:	English
Pubblicazione:	2011

Documenti analoghi

Urinary CXCL9 and CXCL10 Levels and Acute Renal Graft Rejection
di: H Senturk Ciftci, et al.
Pubblicazione: (2019-05-01)

Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
di: Svensson Per-Arne, et al.
Pubblicazione: (2006-06-01)

The effect of transplantation of cultured autologous melanocytes on CXCL9, CXCL10 and CXCL11 expressions in vitiligo
di: Chen Xu, et al.
Pubblicazione: (2023-01-01)

The impact of Th17 cells on transplant rejection and the induction of tolerance.
di: Heidt, S, et al.
Pubblicazione: (2010)

Clinical significance of serum CXCL9, CXCL10, and CXCL11 in patients with lupus nephritis
di: Shuo Wang, et al.
Pubblicazione: (2024-08-01)

CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
di: Xin Yu, et al.
Pubblicazione: (2022-11-01)

Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
di: Hamid Najmaddini, et al.
Pubblicazione: (2014-03-01)

Transforming kidney transplant monitoring with urine CXCL9 and CXCL10: practical clinical implementation
di: Claire Tinel, et al.
Pubblicazione: (2024-09-01)

Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
di: Peter S Fenwick, et al.
Pubblicazione: (2015-01-01)

High Levels of CXCL8 and Low Levels of CXCL9 and CXCL10 in Women with Maternal RhD Alloimmunization
di: Juliana Araújo de Carvalho Schettini, et al.
Pubblicazione: (2017-07-01)

An Antibody-Aptamer-Hybrid Lateral Flow Assay for Detection of CXCL9 in Antibody-Mediated Rejection after Kidney Transplantation
di: Lisa K. Seiler, et al.
Pubblicazione: (2022-01-01)

The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression
di: Xiaowan Yin, et al.
Pubblicazione: (2019-12-01)

Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
di: Alireza Nazari, et al.
Pubblicazione: (2020-03-01)

Biomarker Significance of Serum CXCL8, CXCL10 and CXCL16 in Breast Tumors of Iraqi Patients
di: Aseel F Khalaf, et al.
Pubblicazione: (2020-03-01)

CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
di: Monika Zajkowska, et al.
Pubblicazione: (2023-10-01)

Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation.
di: Heidt, S, et al.
Pubblicazione: (2011)

Pretransplant characteristics of kidney transplant recipients that predict posttransplant outcome
di: Martin Tepel, et al.
Pubblicazione: (2022-07-01)

Changing pattern and safety of pretransplant malignancy in kidney transplant recipients
di: Tae Hyun Ban, et al.
Pubblicazione: (2019-12-01)

Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts
di: Cristina Antinozzi, et al.
Pubblicazione: (2021-05-01)

The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner
di: Victoria Callahan, et al.
Pubblicazione: (2021-06-01)

Elevated Plasma CXCL8 Concentrations in Significant Fibrosis but Not in Subclinical Rejection After Adult Liver Transplantation
di: Alejandro Campos-Murguia, MD, et al.
Pubblicazione: (2024-03-01)

Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10.
di: Luciana Gabriel Nogueira, et al.
Pubblicazione: (2012-01-01)

Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line
di: Ari Matsumoto, et al.
Pubblicazione: (2023-04-01)

Th17: contributors to allograft rejection and a barrier to the induction of transplantation tolerance?
di: Chadha, R, et al.
Pubblicazione: (2011)

Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis
di: Pavithra Sampath, et al.
Pubblicazione: (2023-05-01)

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance
di: Ilias Masouris, et al.
Pubblicazione: (2021-03-01)

Pertinent issues in pretransplant recipient workup
di: Pranjal Modi
Pubblicazione: (2007-01-01)

Examination of serum miRNA levels in kidney transplant recipients with acute rejection.
di: Betts, G, et al.
Pubblicazione: (2014)

Examination of serum miRNA levels in kidney transplant recipients with acute rejection
di: Betts, G, et al.
Pubblicazione: (2014)

CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE
di: Maximilian N. Kinzler, et al.
Pubblicazione: (2023-03-01)

Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
di: Christian Koch, et al.
Pubblicazione: (2022-12-01)

CXCR7 functions as a scavenger for CXCL12 and CXCL11.
di: Ulrike Naumann, et al.
Pubblicazione: (2010-02-01)

CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
di: Hara Takahiko, et al.
Pubblicazione: (2014-05-01)

Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
di: Riley M. Larkin, et al.
Pubblicazione: (2024-05-01)

Correction to: Augmentation of tumor expression of HLADR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
di: Riley M. Larkin, et al.
Pubblicazione: (2024-09-01)

Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone
di: Bin Huang, et al.
Pubblicazione: (2016-12-01)

Serum CXCL 9 as a Potential Biomarker for Patients with Ulcerative Colitis
di: Mohammed A. Qusay, et al.
Pubblicazione: (2024-07-01)

CXCL9/CXCL10 as biomarkers the monitoring of treatment responses in Pulmonary TB patients: a systematic review and meta-analysis
di: Zeyou Wei, et al.
Pubblicazione: (2024-09-01)

Glucocorticoids target the CXCL9/CXCL10-CXCR3 axis and confer protection against immune-mediated kidney injury
di: Jan-Hendrik Riedel, et al.
Pubblicazione: (2023-01-01)

CXCL9 and CXCL10 display an age-dependent profile in Chagas patients: a cohort study of aging in Bambui, Brazil
di: Fernanda Fortes de Araújo, et al.
Pubblicazione: (2020-05-01)